ASP Isotopes (NASDAQ:ASPI) Stock Price Up 9.1% – Here’s Why

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price was up 9.1% on Wednesday . The stock traded as high as $6.15 and last traded at $6.2090. Approximately 714,397 shares changed hands during trading, a decline of 84% from the average daily volume of 4,448,447 shares. The stock had previously closed at $5.69.

Analyst Ratings Changes

ASPI has been the topic of a number of research analyst reports. Loop Capital set a $15.00 target price on ASP Isotopes in a report on Monday, October 27th. Cantor Fitzgerald started coverage on ASP Isotopes in a report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price objective for the company. Canaccord Genuity Group restated a “buy” rating and set a $11.00 target price on shares of ASP Isotopes in a report on Monday, November 24th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $13.00.

ASP Isotopes Trading Up 8.7%

The stock has a 50-day simple moving average of $8.24 and a two-hundred day simple moving average of $8.68. The firm has a market cap of $685.55 million, a PE ratio of -4.74 and a beta of 3.41. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14.

ASP Isotopes (NASDAQ:ASPI) last issued its earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05). The company had revenue of $4.89 million during the quarter, compared to analysts’ expectations of $2.25 million. ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%. As a group, sell-side analysts anticipate that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Buying and Selling at ASP Isotopes

In related news, Chairman Paul Elliot Mann sold 162,153 shares of the stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $5.75, for a total transaction of $932,379.75. Following the completion of the sale, the chairman owned 7,759,538 shares in the company, valued at approximately $44,617,343.50. This trade represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Robert Ainscow sold 67,500 shares of ASP Isotopes stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $7.51, for a total transaction of $506,925.00. Following the sale, the chief executive officer owned 1,579,693 shares in the company, valued at approximately $11,863,494.43. The trade was a 4.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 512,091 shares of company stock valued at $3,699,245 over the last 90 days. 14.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Quantbot Technologies LP purchased a new stake in shares of ASP Isotopes in the third quarter worth about $34,000. Ameritas Investment Partners Inc. increased its stake in ASP Isotopes by 41.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after acquiring an additional 1,600 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in shares of ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after acquiring an additional 2,548 shares in the last quarter. Close Asset Management Ltd bought a new position in shares of ASP Isotopes during the 3rd quarter valued at approximately $72,000. Finally, Tower Research Capital LLC TRC boosted its position in shares of ASP Isotopes by 96.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 10,890 shares of the company’s stock valued at $80,000 after acquiring an additional 5,353 shares during the last quarter. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.